• Azenta completed the sale of B Medical Systems to Thelema on July 1, 2026, closing a deal first disclosed on Dec. 29, 2025.
• Fixed purchase price of USD 63 million in cash, including USD 35 million funded via a short-term secured vendor loan from an Azenta subsidiary.
• Transaction aligns with Azenta’s plan to simplify its portfolio and focus on core life sciences businesses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azenta Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607080800PR_NEWS_USPR_____NE99988) on July 08, 2026, and is solely responsible for the information contained therein.